Business Context and Reporting Period
Company: Chemed Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended March 31, 1995
Business Overview: Chemed operates through four primary segments: National Sanitary Supply, Roto-Rooter, Veratex, and Patient Care. The company reported 9,868,060 shares of common stock outstanding as of April 28, 1995.
Key Financial Metrics
| Metric (in thousands) | Q1 1995 | Q1 1994 |
|---|---|---|
| Total Sales and Service Revenues | $169,858 | $152,069 |
| Income from Operations | $6,696 | $5,670 |
| Net Income | $6,286 | $5,677 |
| Earnings Per Share (Diluted) | $0.64 | $0.58 |
| Operating Cash Flow | $3,119 | $8,833 |
| Cash and Cash Equivalents (Ending) | $1,552 | $12,833 |
| Total Debt (Current + Long-term) | $122,550 | N/A |
| Unused Lines of Credit | $34,300 | N/A |
Note: Debt figures derived from Balance Sheet (Bank notes, current portion of long-term debt, and long-term debt).
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 12% year-over-year, driven by double-digit gains in National Sanitary Supply (13%) and Patient Care (36%).
- Profitability: Income from continuing operations rose 66% to $5.4 million, primarily due to improved operating margins in core segments and higher investment gains.
- Investment Gains: "Other income - net" increased significantly to $5.6 million (from $3.1 million) due to $3.7 million in gains on the sale of investments, compared to $1.6 million in the prior year.
- Cash Flow: Operating cash flow decreased to $3.1 million from $8.8 million, largely due to changes in working capital (increases in receivables and inventory) and lower proceeds from discontinued operations.
- Discontinued Operations: Q1 1995 included a $901,000 after-tax tax adjustment related to a 1991 sale. Q1 1994 included $2.4 million in gains/earnings from the Omnicare investment.
Guidance, Outlook, and Risks
- Segment Outlook:
- National Sanitary Supply: Management expects continued sales and earnings growth in 1995 due to new sales/training programs and improved pricing.
- Roto-Rooter: Margins improved to 8.9% due to cost management. The company sold a marginally profitable maintenance subsidiary to focus on core appliance and HVAC repair.
- Veratex: Operating margins declined to 5.8% due to price competition in the retail segment, though wholesale margins stabilized.
- Patient Care: Strong 36% revenue growth attributed to new branch openings.
- Liquidity: Management considers liquidity satisfactory with $34.3 million in unused credit lines.
- Risks/Contingencies:
- Price competition in the retail pharmacy segment (Veratex).
- Reliance on investment gains for a portion of net income.
- Tax provision adjustments related to historical transactions.
Investor Verification Checklist
- Investment Gains: Verify the sustainability of the $3.7 million gain on sale of investments, which significantly boosted Q1 1995 net income.
- Working Capital: Review the $1.2 million increase in accounts receivable and $1.0 million increase in inventory, which reduced operating cash flow.
- Discontinued Operations: Confirm the nature of the $901,000 tax adjustment in discontinued operations to ensure it does not impact future tax liabilities.
- Segment Margins: Monitor Veratex's retail segment margins given the noted industry consolidation and price competition.
- Debt Structure: Assess the $122.5 million total debt load against the $34.3 million available credit line for future liquidity needs.